InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the full record of transactions filed by Srivastava Sapna. Officer active across 5 companies, notably Innoviva, Inc.. In total, 12 reports have been published. Activity tracked since 22 May 2023. The latest transaction was disclosed on 15 July 2026 (U). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 条申报中的 12 条
Srivastava Sapna is a director at Aura Biosciences, Inc., Innoviva, Inc., ALUMIS INC., Nuvalent, Inc. and Tourmaline Bio, Inc. The record shows 7 filings in total, with recent sampled filings dated from 2023-05-24 to 2026-07-02, and buy and sell amounts of EUR 0 in that sample, with attribution as the prevailing transaction nature.